Clinical trial · Interventional
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomised Clinical Trial
NCT05494086CI-TRIAL-00077060recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DPLDG | Procedure | — | UNRESOLVED |
| LDG | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- DPLDG arm
- description
- Dual-port laparoscopic distal gastrectomy
- interventionNames
- Procedure: DPLDG
- type
- ACTIVE_COMPARATOR
- label
- LDG arm
- description
- Laparoscopic distal gastrectomy
- interventionNames
- Procedure: LDG
Primary outcomes (1)
- measure
- Early operative morbidity
- timeFrame
- Within 30 days following surgery
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. patients within 18--75 years old; 2. patients with a preoperative pathological diagnosis of gastric adenocarcinoma; 3. patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomography); 4. patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results; 5. patients without severe heart, liver, lung, or kidney dysfunction; 6. patients with an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1; and (7) patients with American Society of Anesthesiologists (ASA) I-II. Exclusion Criteria: 1. patients with a history of upperabdominal surgery; 2. patients who presentedas an emergency case; 3. patients with other histories of malignant diseases within 5 years; 4. patients with prior neoadjuvant chemotherapy or radiation therapy; and (5)patients who need simultaneous surgical treatment for other malignant diseases.
References
Publications (0)
Data not yet available
No reference posted for this study.